LL-37

LL-37 is a human cathelicidin antimicrobial peptide studied for its role in innate immunity, wound healing, and inflammatory modulation. It is derived from the precursor protein hCAP-18 and has been widely researched for its antimicrobial and immunoregulatory properties.

In laboratory studies, LL-37 has been investigated for its ability to disrupt bacterial membranes, regulate immune signaling, and promote tissue repair. It is also considered in experimental models exploring skin health, infection defense, and inflammatory pathways.

Studied for broad-spectrum antimicrobial and antiviral activity

Investigated for influence on immune system modulation

Explored for effects on wound healing and tissue regeneration

Considered in preclinical models of infection, inflammation, and skin health